
USGI Medical Stock
USGI Medical develops technologies that enable incisionless surgeries that treat diseases through the natural passageways of the body.
Sign up today and learn more about USGI Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About USGI Medical Stock
USGI Medical develops technologies that enable incisionless procedures which help patients return to normal activities and lifestyles faster compared to traditional laparoscopic and open surgery. USGI’s Incisionless Operating Platform (IOP) provides surgeons the operating platform and specialized tools they need to perform surgery through a patient’s mouth or other natural orifices, reducing the need for external incisions into the abdomen. USGI has demonstrated the breakthrough capability to reliably and durably fixate and plicate GI tract tissue without an incision. Operating through the body’s natural orifices offers promise for less pain, shorter hospital stays, reduced risk of wound infection and no external scars – and is rapidly becoming an option demanded by patients and healthcare providers.
Funding History
December 2001 | $3.5M |
---|---|
December 2003 | $12.0M |
July 2006 | $21.0M |
May 2012 | $16.5M |
July 2014 | $9.0M |
January 2015 | $19.5M |
Management
CEO
Carlos Babini
COO
Tracy Maahs
Chairman of the Board
Guy P. Nohra
Press
prnewswire - Apr, 4 2016
Global Bariatric Surgery Devices Market Analysis & Trends Report 2016 - Forecasts to 2025 for the $3.8 Billion Industry - Research and Marketsbusinesswire - Nov, 4 2015
Research and Markets: U.S. Markets for Obesity Drugs & Devices 2015 - New Obesity Drugs and Devices Market is Estimated at $374.7 Millionbusinesswire - Sep, 29 2015
Research and Markets: Global Cholecystitis Clinical Trials Review, H1, 2015businesswire - Sep, 29 2015
Research and Markets: Global Market Study on Obesity Surgery Devices 2014-2020 - Market to Reach $2.4 Billion Industrybusinesswire - Sep, 29 2015
Research and Markets: Global Endoscopy Devices Market 2015-2019 - What are the Market Opportunities and Threats Faced by the Key Vendors?fiercemedicaldevices - Sep, 29 2015
Obesity player USGI raises $19.5M to complete U.S. pivotal trial, FDA submissionEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase